Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
- PMID: 19864265
- PMCID: PMC2842615
- DOI: 10.1098/rsif.2009.0379
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
Abstract
This paper provides an extensive overview of published studies on the development and applications of three-dimensional bone tissue engineering (TE) scaffolds with potential capability for the controlled delivery of therapeutic drugs. Typical drugs considered include gentamicin and other antibiotics generally used to combat osteomyelitis, as well as anti-inflammatory drugs and bisphosphonates, but delivery of growth factors is not covered in this review. In each case reviewed, special attention has been given to the technology used for controlling the release of the loaded drugs. The possibility of designing multifunctional three-dimensional bone TE scaffolds for the emerging field of bone TE therapeutics is discussed. A detailed summary of drugs included in three-dimensional scaffolds and the several approaches developed to combine bioceramics with various polymeric biomaterials in composites for drug-delivery systems is included. The main results presented in the literature are discussed and the remaining challenges in the field are summarized with suggestions for future research directions.
Figures


Similar articles
-
Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.Expert Opin Drug Deliv. 2013 Oct;10(10):1353-65. doi: 10.1517/17425247.2013.808183. Epub 2013 Jun 19. Expert Opin Drug Deliv. 2013. PMID: 23777443 Review.
-
Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.Adv Drug Deliv Rev. 2015 Nov 1;94:77-95. doi: 10.1016/j.addr.2015.09.007. Epub 2015 Sep 28. Adv Drug Deliv Rev. 2015. PMID: 26415888 Review.
-
Current state of fabrication technologies and materials for bone tissue engineering.Acta Biomater. 2018 Oct 15;80:1-30. doi: 10.1016/j.actbio.2018.09.031. Epub 2018 Sep 22. Acta Biomater. 2018. PMID: 30248515 Review.
-
Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration.J Biomed Mater Res B Appl Biomater. 2010 Oct;95(1):36-46. doi: 10.1002/jbm.b.31680. J Biomed Mater Res B Appl Biomater. 2010. PMID: 20665683
-
Engineering Pre-vascularized Scaffolds for Bone Regeneration.Adv Exp Med Biol. 2015;881:79-94. doi: 10.1007/978-3-319-22345-2_5. Adv Exp Med Biol. 2015. PMID: 26545745 Review.
Cited by
-
Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds.Biomaterials. 2013 Jan;34(2):452-9. doi: 10.1016/j.biomaterials.2012.10.005. Epub 2012 Oct 23. Biomaterials. 2013. PMID: 23099062 Free PMC article.
-
Advances in three-dimensional bioprinting for hard tissue engineering.Tissue Eng Regen Med. 2016 Dec 17;13(6):622-635. doi: 10.1007/s13770-016-0145-4. eCollection 2016 Dec. Tissue Eng Regen Med. 2016. PMID: 30603444 Free PMC article. Review.
-
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches.Pharmaceutics. 2020 May 6;12(5):428. doi: 10.3390/pharmaceutics12050428. Pharmaceutics. 2020. PMID: 32384753 Free PMC article. Review.
-
Gentamicin-loaded silk/nanosilver composite scaffolds for MRSA-induced chronic osteomyelitis.R Soc Open Sci. 2019 May 1;6(5):182102. doi: 10.1098/rsos.182102. eCollection 2019 May. R Soc Open Sci. 2019. PMID: 31218036 Free PMC article.
-
Ag-doped 45S5 Bioglass®-based bone scaffolds by molten salt ion exchange: processing and characterisation.J Mater Sci Mater Med. 2011 Mar;22(3):557-69. doi: 10.1007/s10856-011-4240-8. Epub 2011 Feb 4. J Mater Sci Mater Med. 2011. PMID: 21293911
References
-
- Adams A. P., Santschi E. M., Mellencamp M. A. 1999. Antibacterial properties of a silver chloride-coated nylon wound dressing. Vet. Surg. 28, 219–225. - PubMed
-
- Ambrose C. G., Gogola G. R., Clyburn T. A., Raymond A. K., Peng A. S., Mikos A. G. 2003. Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin. Orthop. Relat. Res. 415, 279–285. (10.1097/01.blo.0000093920.26658.ae) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical